Ricevi le ultime notizie sulle azioni Jaguar Health con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di JAGX

Ultime notizie per

Jaguar Health

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Jaguar Health Inc

News

Press Releases

Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates

Earnings

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)

Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs

Events

Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts

ADVM

ASPI

BNZI

CLNN

CSE:METG

CSE:TCEC

CUAUF

CYIO

DERM

EHGO

ELRRF

FFAI

FUFU

GOVX

GROV

HDRSF

HSCS

IMRN

JAGX

KBRIF

KPGHF

LGCXF

MGSTF

NCSM

NTRB

OMEX

OPWEF

PHXHF

PUMXF

RGBP

SEVCF

SRFM

SRGZ

TCEFF

TSX:ELO

TSX:VGZ

TSXV:CCCM

TSXV:HI

TSXV:KRI

TSXV:LG

TSXV:OPW

TSXV:PUMA

TSXV:UCU

TSXV:VROY

USEG

UURAF

UXIN

VROYF

XXII

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Akanda

Artelo Biosciences

Aspire Biopharma Holdings, Inc. - Warrant

Aspire Biopharma Hldgs

Clearmind Medicine

CNS Pharma

China Pharma Holding

Enveric Biosciences

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals

Nutriband

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

PainReform

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Reviva Pharmaceuticals Holdings, Inc. - Warrants

Reviva Pharmaceuticals

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

SciSparc

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

TNF Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

VYNE Therapeutics

XORTX Therapeutics

cbdMD

First Berlin

Comments

Jaguar Health Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO